NO20003051D0 - Metode for administrering av AspB28-humant insulin - Google Patents

Metode for administrering av AspB28-humant insulin

Info

Publication number: NO20003051D0
Authority: NO; Norway
Prior art keywords: administration; human insulin; aspb28 human; aspb28; insulin
Prior art date: 1998-01-08

Application number

NO20003051A

Other languages

English (en)

Other versions

NO20003051L (no

Inventor

Richard Dennis Dimarchi

Roger Garrick Harrison

Ronald Keith Wolff

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-08

Filing date

2000-06-14

Publication date

2000-06-14

2000-06-14 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2000-06-14 Publication of NO20003051L publication Critical patent/NO20003051L/no

2000-06-14 Publication of NO20003051D0 publication Critical patent/NO20003051D0/no

Links

101000976075 Homo sapiens Insulin Proteins 0.000 title 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Zoology (AREA)
Obesity (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

NO20003051A 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin NO20003051D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7075298P	1998-01-08	1998-01-08
PCT/US1999/000290 WO1999034815A1 (en)	1998-01-08	1999-01-07	Method for administering aspb28-human insulin

Publications (2)

Publication Number	Publication Date
NO20003051L NO20003051L (no)	2000-06-14
NO20003051D0 true NO20003051D0 (no)	2000-06-14

Family

ID=22097181

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20003051A NO20003051D0 (no)	1998-01-08	2000-06-14	Metode for administrering av AspB28-humant insulin
NO20003050A NO20003050L (no)	1998-01-08	2000-06-14	Metode for Õ administrere monomere insulinanaloger

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20003050A NO20003050L (no)	1998-01-08	2000-06-14	Metode for Õ administrere monomere insulinanaloger

Country Status (16)

Country	Link
US (2)	US20010053761A1 (no)
EP (2)	EP0951911A3 (no)
JP (2)	JP2002500193A (no)
KR (2)	KR20010033940A (no)
CN (2)	CN1195543C (no)
AU (2)	AU747619B2 (no)
BR (2)	BR9906796A (no)
CA (2)	CA2317733A1 (no)
EA (2)	EA200000747A1 (no)
HU (2)	HUP0101293A3 (no)
IL (2)	IL137105A0 (no)
NO (2)	NO20003051D0 (no)
PL (2)	PL341592A1 (no)
TR (2)	TR200001891T2 (no)
WO (2)	WO1999034816A1 (no)
ZA (2)	ZA99105B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6131567A (en) *	1993-01-29	2000-10-17	Aradigm Corporation	Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) *	1998-12-10	2006-08-03	Akwete Adjei	Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) *	2000-06-09	2005-02-22	Advanced Inhalation Research, Inc.	High efficient delivery of a large therapeutic mass aerosol
AU5453300A (en) *	1999-06-29	2001-01-31	Eli Lilly And Company	Insulin crystals for pulmonary administration
US6458387B1 (en) *	1999-10-18	2002-10-01	Epic Therapeutics, Inc.	Sustained release microspheres
DE60138641D1 (de)	2000-10-27	2009-06-18	Baxter Healthcare Sa	Herstellung von mikrokügelchen
US20030064033A1 (en) *	2001-08-16	2003-04-03	Brown Larry R.	Propellant-based microparticle formulations
EP1944016A1 (en)	2001-08-16	2008-07-16	Baxter International Inc.	Propellant-based microparticle formulatons
EP1461020A4 (en) *	2001-12-07	2008-10-29	Map Pharmaceuticals Inc	SYNTHESIS OF SMALL PARTICLES
WO2003059253A2 (en) *	2001-12-21	2003-07-24	Smithkline Beecham Corporation	Compositions and methods for altering glucose production
US7118010B2 (en)	2002-05-10	2006-10-10	Oriel Therapeutics, Inc.	Apparatus, systems and related methods for dispensing and /or evaluating dry powders
US7677411B2 (en)	2002-05-10	2010-03-16	Oriel Therapeutics, Inc.	Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US6985798B2 (en) *	2002-05-10	2006-01-10	Oriel Therapeutics, Inc.	Dry powder dose filling systems and related methods
US6889690B2 (en)	2002-05-10	2005-05-10	Oriel Therapeutics, Inc.	Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
AU2003251760A1 (en)	2002-06-27	2004-01-19	Oriel Therapeutics, Inc.	Apparatus and methods for dispensing dry powders
US7377277B2 (en) *	2003-10-27	2008-05-27	Oriel Therapeutics, Inc.	Blister packages with frames and associated methods of fabricating dry powder drug containment systems
WO2005041848A2 (en)	2003-10-27	2005-05-12	Oriel Therapeutics, Inc.	Dry powder drug containment system packages with tabs, inhalers and associated methods
US7451761B2 (en)	2003-10-27	2008-11-18	Oriel Therapeutics, Inc.	Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
WO2005065756A2 (en)	2003-12-30	2005-07-21	Oriel Therapeutics, Inc.	Dry powder nebulizers and associated methods of dispensing dry powders
US7624733B2 (en)	2004-02-09	2009-12-01	Oriel Therapeutics, Inc.	Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
WO2006031775A2 (en) *	2004-09-13	2006-03-23	Oriel Therapeutics, Inc.	Dry powder inhalers that inhibit agglomeration, related devices and methods
CA2618520C (en) *	2005-08-25	2015-01-27	Oriel Therapeutics, Inc.	Drug containment systems with sticks, related kits, dry powder inhalers and methods
AU2007210177C1 (en)	2006-01-31	2012-11-01	Oriel Therapeutics, Inc.	Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (en) *	2007-11-15	2009-05-20	Novo Nordisk A/S	Pharmaceutical compositions for pulmonary or nasal delivery of peptides
MX2011003244A (es)	2008-09-26	2011-04-28	Oriel Therapeutics Inc	Inhaladores con discos de vias aereas con canales de vias aereas discretas y discos y metodos relacionados.
US8887722B2 (en) *	2008-09-26	2014-11-18	Oriel Therapeutics, Inc.	Inhaler mechanisms with radially biased piercers and related methods
CA2732840C (en) *	2008-09-26	2016-07-05	Oriel Therapeutics, Inc.	Dry powder inhalers with dual piercing members and related devices and methods
WO2010039201A2 (en) *	2008-09-30	2010-04-08	Oriel Therapeutics, Inc.	Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
WO2010039200A2 (en) *	2008-09-30	2010-04-08	Oriel Therapeutics, Inc.	Dry powder inhalers with endless strips and cooperating piercers and related methods
WO2010039202A2 (en) *	2008-10-01	2010-04-08	Oriel Therapeutics, Inc.	Dry powder inhalers with rotating piercing mechanisms and related devices and methods
JP5341532B2 (ja) *	2009-01-19	2013-11-13	第一電子工業株式会社	１対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) *	2010-01-11	2014-01-29	杨国汉	改善胰岛素在溶液中稳定性的方法
EP2362796A4 (en)	2010-01-27	2014-10-08	Aespira Ltd	dry powder inhaler
USD635246S1 (en)	2010-03-26	2011-03-29	Oriel Therapeutics, Inc.	Dose disk for dry powder inhalers
USD641076S1 (en)	2010-03-26	2011-07-05	Oriel Therapeutics, Inc.	Dry powder inhaler
US11491288B2 (en)	2014-01-08	2022-11-08	Seroton, Inc.	Dispenser for dry-powder inhalation devices
US10238820B2 (en)	2014-01-08	2019-03-26	Seroton, Inc.	Dry-powder inhalation device
WO2024100652A1 (en)	2022-11-07	2024-05-16	Kritzman Kadron Amnon	High performance dry powder inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK179286D0 (da) *	1986-04-18	1986-04-18	Nordisk Gentofte	Insulinpraeparat
IL93282A (en) *	1989-02-09	1995-08-31	Lilly Co Eli	Insulin analogues
US5230884A (en) *	1990-09-11	1993-07-27	University Of Wales College Of Cardiff	Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) *	1993-01-29	2000-10-17	Aradigm Corporation	Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
DK72793D0 (da) *	1993-06-21	1993-06-21	Novo Nordisk As	Nyt produkt
EP0705275B1 (en) *	1993-06-21	1999-02-03	Novo Nordisk A/S	Asp-b28 insulin crystals
TW402506B (en) *	1993-06-24	2000-08-21	Astra Ab	Therapeutic preparation for inhalation
US5451569A (en) *	1994-04-19	1995-09-19	Hong Kong University Of Science And Technology R & D Corporation Limited	Pulmonary drug delivery system
US5461031A (en) *	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
US5547929A (en) *	1994-09-12	1996-08-20	Eli Lilly And Company	Insulin analog formulations
AR002976A1 (es) *	1995-03-31	1998-05-27	Lilly Co Eli	Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
IL118127A0 (en) *	1995-05-05	1996-09-12	Lilly Co Eli	Single chain insulin with high bioactivity

1999
- 1999-01-06 US US09/226,412 patent/US20010053761A1/en not_active Abandoned
- 1999-01-06 US US09/226,420 patent/US20010007853A1/en not_active Abandoned
- 1999-01-07 JP JP2000527264A patent/JP2002500193A/ja not_active Withdrawn
- 1999-01-07 WO PCT/US1999/000324 patent/WO1999034816A1/en not_active Ceased
- 1999-01-07 HU HU0101293A patent/HUP0101293A3/hu unknown
- 1999-01-07 JP JP2000527263A patent/JP2002500192A/ja not_active Withdrawn
- 1999-01-07 EA EA200000747A patent/EA200000747A1/ru unknown
- 1999-01-07 PL PL99341592A patent/PL341592A1/xx not_active Application Discontinuation
- 1999-01-07 AU AU23122/99A patent/AU747619B2/en not_active Ceased
- 1999-01-07 PL PL99342745A patent/PL342745A1/xx not_active Application Discontinuation
- 1999-01-07 BR BR9906796-0A patent/BR9906796A/pt not_active Application Discontinuation
- 1999-01-07 AU AU21073/99A patent/AU754707B2/en not_active Ceased
- 1999-01-07 CA CA002317733A patent/CA2317733A1/en not_active Abandoned
- 1999-01-07 ZA ZA9900105A patent/ZA99105B/xx unknown
- 1999-01-07 EP EP99300122A patent/EP0951911A3/en not_active Withdrawn
- 1999-01-07 KR KR1020007007524A patent/KR20010033940A/ko not_active Withdrawn
- 1999-01-07 HU HU0100391A patent/HUP0100391A3/hu unknown
- 1999-01-07 CN CNB998020192A patent/CN1195543C/zh not_active Expired - Fee Related
- 1999-01-07 EP EP99300111A patent/EP0951910A3/en not_active Withdrawn
- 1999-01-07 ZA ZA9900104A patent/ZA99104B/xx unknown
- 1999-01-07 CA CA002317739A patent/CA2317739A1/en not_active Abandoned
- 1999-01-07 TR TR2000/01891T patent/TR200001891T2/xx unknown
- 1999-01-07 IL IL13710599A patent/IL137105A0/xx unknown
- 1999-01-07 BR BR9906813-3A patent/BR9906813A/pt not_active IP Right Cessation
- 1999-01-07 WO PCT/US1999/000290 patent/WO1999034815A1/en not_active Ceased
- 1999-01-07 IL IL13715099A patent/IL137150A0/xx unknown
- 1999-01-07 TR TR2000/01892T patent/TR200001892T2/xx unknown
- 1999-01-07 EA EA200000748A patent/EA200000748A1/ru unknown
- 1999-01-07 CN CN99802020A patent/CN1287492A/zh active Pending
- 1999-01-07 KR KR1020007007525A patent/KR20010033941A/ko not_active Withdrawn
2000
- 2000-06-14 NO NO20003051A patent/NO20003051D0/no not_active Application Discontinuation
- 2000-06-14 NO NO20003050A patent/NO20003050L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EA200000748A1 (ru)	2000-12-25
BR9906796A (pt)	2000-11-14
JP2002500193A (ja)	2002-01-08
US20010007853A1 (en)	2001-07-12
AU2312299A (en)	1999-07-26
HUP0101293A3 (en)	2001-12-28
EP0951910A3 (en)	2002-06-19
ZA99105B (en)	2000-07-07
CA2317733A1 (en)	1999-07-15
ZA99104B (en)	2000-07-07
KR20010033941A (ko)	2001-04-25
IL137105A0 (en)	2001-06-14
CN1287491A (zh)	2001-03-14
HUP0100391A2 (hu)	2001-08-28
BR9906813A (pt)	2001-03-20
NO20003051L (no)	2000-06-14
EP0951910A2 (en)	1999-10-27
CA2317739A1 (en)	1999-07-15
WO1999034815A1 (en)	1999-07-15
EP0951911A2 (en)	1999-10-27
AU754707B2 (en)	2002-11-21
CN1287492A (zh)	2001-03-14
HUP0100391A3 (en)	2001-12-28
AU747619B2 (en)	2002-05-16
IL137150A0 (en)	2001-07-24
WO1999034816A1 (en)	1999-07-15
HUP0101293A2 (hu)	2001-08-28
PL341592A1 (en)	2001-04-23
US20010053761A1 (en)	2001-12-20
NO20003050D0 (no)	2000-06-14
AU2107399A (en)	1999-07-26
NO20003050L (no)	2000-06-14
CN1195543C (zh)	2005-04-06
PL342745A1 (en)	2001-07-02
JP2002500192A (ja)	2002-01-08
EP0951911A3 (en)	2002-06-19
KR20010033940A (ko)	2001-04-25
EA200000747A1 (ru)	2000-12-25
TR200001892T2 (tr)	2000-11-21
TR200001891T2 (tr)	2000-11-21

Legal Events

Date	Code	Title	Description
2002-10-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
PL341592A1 (en)	2001-04-23	Method of administering human aspb28 insulin
DE69935681D1 (de)	2007-05-10	Vorrichtungen zur Medikamentverabreichung
NO20006630D0 (no)	2000-12-22	Farmasöytisk sammensetning for behandlingen av diabetes
IS5245A (is)	1999-11-11	Lyfjablanda úr ómeprasól
IL147217A0 (en)	2002-11-10	New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
CY2007001I2 (el)	2009-11-04	Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DK1223997T3 (da)	2009-03-30	Medicinsk infusionssæt
DE60043305D1 (de)	2009-12-24	Pharmazeutische zubereitungen zur behandlung von insulinresitenz
FI972292A0 (fi)	1997-05-30	Administrering av diabetes
EE04418B1 (et)	2005-02-15	Moksifloksatsiini farmatseutiline preparaat
NO20002851D0 (no)	2000-06-02	Blandinger for nasal administrasjon av medikamenter
NO20026212D0 (no)	2002-12-23	Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
NO20013958L (no)	2001-10-15	Legemiddel for behandling av höyt blodtrykk
ZA984268B (en)	1999-06-23	Method and composition for administering taxanes orally to human patients
FI964619A7 (fi)	1996-11-19	Epilepsialääkkeiden iholle annostelu
HUP0300402A3 (en)	2005-07-28	Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
NO20014812D0 (no)	2001-10-03	Fremgangsmåte for tilveiebringelse av kosmetisk/medisinsk terapi
NO20020784D0 (no)	2002-02-18	Medikament for behandling av brudd
DE69832974D1 (de)	2006-02-02	Gerät zur intrakardialen verabreichung von medikamenten
IL155819A0 (en)	2003-12-23	Methods of treatment comprising administration of substance p
NO20022990D0 (no)	2002-06-20	Fremgangsmåte og sammensetning for behandling av smerte
NO20001895L (no)	2000-04-12	Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer
ID28817A (id)	2001-07-05	Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
UA33799A (uk)	2001-02-15	Спосіб одержання препарату інсуліну пролонгованої дії
ITFI980203A0 (it)	1998-09-09	Metodo e dispositivo per la somministrazione di farmaci